ArticleMultiple sclerosis (Houndmills, Basingstoke, England)2023
Recurrent disability progression endpoints in multiple sclerosis clinical trials.
Alexandra Bühler et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this paperpooled itcites it